Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Bajaj Finserv Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesDivi's Laboratories Limited8.84814522728.9114
Domestic EquitiesSun Pharmaceutical Industries Limited8.012115223426.1797
Domestic EquitiesApollo Hospitals Enterprise Limited5.89582735519.2648
Domestic EquitiesAurobindo Pharma Limited5.532715281818.0784
Domestic EquitiesCipla Limited5.176111191116.9131
Domestic EquitiesPiramal Pharma Limited4.191679531613.6961
Domestic EquitiesNeuland Laboratories Limited3.8728833912.6544
Domestic EquitiesEmcure Pharmaceuticals Limited3.42448200211.1892
Domestic EquitiesFortis Healthcare Limited3.251412018310.6242
Domestic EquitiesRubicon Research Limited3.113214943210.1726
Domestic EquitiesGlenmark Pharmaceuticals Limited2.7295438238.9189
Domestic EquitiesLupin Limited2.3421362787.6528
Domestic EquitiesBiocon Limited2.28521895687.4671
Domestic EquitiesIPCA Laboratories Limited2.1922504837.1630
Domestic EquitiesPfizer Limited2.0323133146.6406
Domestic EquitiesVijaya Diagnostic Centre Limited2.0041617186.5483
Domestic EquitiesEternal Limited1.99332342496.5133
Domestic EquitiesZydus Wellness Limited1.91861379056.2692
Domestic EquitiesSanofi Consumer Healthcare India Limited1.9176138636.2659
Domestic EquitiesGodrej Consumer Products Limited1.8702500006.1110
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.8011237925.8852
Domestic EquitiesShaily Engineering Plastics Limited1.7171248095.6108
Domestic EquitiesDr. Lal Path Labs Limited1.5988352365.2241
Domestic EquitiesAbbott India Limited1.543817385.0445
Domestic EquitiesMedi Assist Healthcare Services Limited1.41441005904.6216
Domestic EquitiesMedPlus Health Services Limited1.2762516524.1699
Domestic EquitiesTorrent Pharmaceuticals Limited1.2167103263.9755
Domestic EquitiesRainbow Childrens Medicare Limited1.1919295033.8944
Domestic EquitiesJubilant Pharmova Limited1.1492349863.7550
Domestic EquitiesMax Healthcare Institute Limited1.1195350003.6579
Domestic EquitiesHindustan Unilever Limited1.1043155813.6084
Domestic EquitiesSyngene International Limited1.0986551393.5895
Domestic EquitiesTata Consumer Products Limited1.0944300003.5760
Domestic EquitiesEmami Limited1.0480647823.4244
Domestic EquitiesAlembic Pharmaceuticals Limited1.0345399473.3801
Domestic EquitiesMankind Pharma Limited0.9765145263.1906
Domestic EquitiesAstraZeneca Pharma India Limited0.902832672.9498
Domestic EquitiesMarico Limited0.7257315922.3713
Domestic EquitiesKwality Walls (India) Limited **0.0192155810.0626
Total 94.6361 309.2256
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd2.6597 8.6906
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-1.7992 -5.8789
Total 0.8605 2.8117
Derivatives-FuturesMax Healthcare Institute Limited January 2026 Future2.9543918759.6533
Total 2.9543 9.6533
Domestic Mutual Funds UnitsBajaj Finserv Money Market Fund-Direct Plan-Growth1.5490421965.0615
Total 1.5490 5.0615
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.